Cargando…
What is the added value of FeNO as T2 biomarker?
There is increasing evidence about the role of nitric oxide in type 2 (T2) immune response. Fraction of exhaled nitric oxide (FeNO) is a product of airways inflammation and it is increased in patients with asthma. Since Gustaffson published the first article about this biomarker in the 1990s, intere...
Autores principales: | Marcos, María Celeste, Cisneros Serrano, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403133/ https://www.ncbi.nlm.nih.gov/pubmed/36032508 http://dx.doi.org/10.3389/falgy.2022.957106 |
Ejemplares similares
-
The Correlation Between Fractional Exhaled Nitric Oxide (FeNO), Blood Eosinophil Count, Immunoglobulin E Levels, and Spirometric Values in Patients With Asthma
por: Al Ghobain, Mohammed O, et al.
Publicado: (2023) -
296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012) -
The value of FeNO measurement in childhood asthma: uncertainties and perspectives
por: Ferrante, Giuliana, et al.
Publicado: (2013) -
The Role of FeNO in Predicting Asthma
por: Pijnenburg, Mariëlle W.
Publicado: (2019) -
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
por: Maniscalco, Mauro, et al.
Publicado: (2022)